3'-Deoxy-3'-¹8F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer. (2015)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00259-015-3000-2
PubMed Identifier: 25673055
Publication URI: http://europepmc.org/abstract/MED/25673055
Type: Journal Article/Review
Volume: 42
Parent Publication: European journal of nuclear medicine and molecular imaging
Issue: 6
ISSN: 1619-7070